Showing results (1-10 of 66) with videos related to
Sort By:
Pageof 7
Expert Review of Vaccines|June 13, 2022
HIV-1 therapeutic vaccines in clinical development to intensify or replace antiretroviral therapy: the promising results of the Tat vaccineAurelio Cafaro, Barbara EnsoliCurrent Opinion in Biotechnology|November 25, 2004
Nonstructural HIV proteins as targets for prophylactic or therapeutic vaccinesFlavia Ferrantelli, Aurelio Cafaro, Barbara EnsoliSpringer Seminars in Immunopathology|September 20, 2006
Building collaborative networks for HIV/AIDS vaccine development: the AVIP experienceFlavia Ferrantelli, Stefano Buttò, Aurelio Cafaro, et al.Frontiers in Immunology|September 25, 2014
Challenges in HIV Vaccine Research for Treatment and PreventionBarbara Ensoli, Aurelio Cafaro, Paolo Monini, et al.Advances in Experimental Medicine and Biology|January 5, 2010
Innovative approaches to develop prophylactic and therapeutic vaccines against HIV/AIDSAurelio Cafaro, Iole Macchia, Maria Teresa Maggiorella, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 26, 2001
Native HIV-1 Tat protein targets monocyte-derived dendritic cells and enhances their maturation, function, and antigen-specific T cell responsesEmanuele Fanales-Belasio, Sonia Moretti, Filomena Nappi, et al.Vaccines|August 29, 2019
Anti-Tat Immunity in HIV-1 Infection: Effects of Naturally Occurring and Vaccine-Induced Antibodies Against Tat on the Course of the DiseaseAurelio Cafaro, Antonella Tripiciano, Orietta Picconi, et al.Expert Review of Vaccines|January 21, 2020
HIV therapeutic vaccines aimed at intensifying combination antiretroviral therapySonia Moretti, Aurelio Cafaro, Antonella Tripiciano, et al.BMC Infectious Diseases|August 24, 2016
HIV-1 Tat protein vaccination in mice infected with Mycobacterium tuberculosis is safe, immunogenic and reduces bacterial lung pathologyAurelio Cafaro, Giovanni Piccaro, Giuseppe Altavilla, et al.Vaccines|June 10, 2020
The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral ReactivationFrancesco Nicoli, Eleonora Gallerani, Mariaconcetta Sicurella, et al.Pageof 7